GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Cyclically Adjusted PS Ratio

Cangene (FRA:YGE) Cyclically Adjusted PS Ratio : (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Cangene Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cangene Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cangene's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Cyclically Adjusted PS Ratio Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cangene's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Cangene's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cangene's Cyclically Adjusted PS Ratio falls into.



Cangene Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cangene's Cyclically Adjusted Revenue per Share for the quarter that ended in Oct. 2013 is calculated as:

For example, Cangene's adjusted Revenue per Share data for the three months ended in Oct. 2013 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Oct. 2013 (Change)*Current CPI (Oct. 2013)
=0.27/97.1820*97.1820
=0.270

Current CPI (Oct. 2013) = 97.1820.

Cangene Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200401 0.427 81.617 0.508
200404 0.374 82.249 0.442
200407 0.312 82.960 0.365
200410 0.255 83.118 0.298
200501 0.272 83.197 0.318
200504 0.252 84.224 0.291
200507 0.154 84.619 0.177
200510 0.258 85.252 0.294
200601 0.326 85.489 0.371
200604 0.319 86.279 0.359
200607 0.267 86.595 0.300
200610 0.265 86.121 0.299
200701 0.198 86.437 0.223
200704 0.216 88.175 0.238
200707 0.284 88.491 0.312
200710 0.523 88.175 0.576
200801 0.225 88.333 0.248
200804 0.265 89.676 0.287
200807 0.542 91.493 0.576
200810 0.470 90.466 0.505
200901 0.304 89.281 0.331
200904 0.615 89.992 0.664
200907 0.955 90.624 1.024
200910 0.382 90.545 0.410
201001 0.399 90.940 0.426
201004 0.431 91.651 0.457
201007 0.377 92.283 0.397
201010 0.245 92.757 0.257
201101 0.448 93.074 0.468
201104 0.354 94.654 0.363
201107 0.562 94.812 0.576
201110 0.234 95.444 0.238
201201 0.390 95.365 0.397
201204 0.313 96.550 0.315
201207 0.347 95.997 0.351
201210 0.421 96.550 0.424
201301 0.292 95.839 0.296
201304 0.458 96.945 0.459
201307 0.279 97.261 0.279
201310 0.270 97.182 0.270

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cangene  (FRA:YGE) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cangene Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cangene's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines